What is China Biologic Products Holdings Price-to-Operating-Cash-Flow?
As of today (2024-05-11), China Biologic Products Holdings's share price is $119.99.
China Biologic Products Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2020 was $6.68. Hence, China Biologic Products Holdings's Price-to-Operating-Cash-Flow Ratio for today is 17.96.
The historical rank and industry rank for China Biologic Products Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:
CBPO'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 13.46 Med: 17.82 Max: 34.18
Current: 17.82
During the past 13 years, China Biologic Products Holdings's highest Price-to-Operating-Cash-Flow Ratio was 34.18. The lowest was 13.46. And the median was 17.82.
China Biologic Products Holdings's Cash Flow from Operations per share for the
three
months ended in Sep. 2020 was $1.34.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2020 was $6.68.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of China Biologic Products Holdings was 37.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.20% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 3.50% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 11.00% per year.
During the past 13 years, China Biologic Products Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 41.90% per year. The lowest was -10.70% per year. And the median was 15.80% per year.
China Biologic Products Holdings Price-to-Operating-Cash-Flow Historical Data
The historical data trend for China Biologic Products Holdings's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Biologic Products Holdings Price-to-Operating-Cash-Flow Chart
|
China Biologic Products Holdings Annual Data
|
|
Trend |
Dec10 |
Dec11 |
Dec12 |
Dec13 |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
34.59 |
23.77 |
21.28 |
34.34 |
19.75 |
|
China Biologic Products Holdings Quarterly Data
|
|
Dec15 |
Mar16 |
Jun16 |
Sep16 |
Dec16 |
Mar17 |
Jun17 |
Sep17 |
Dec17 |
Mar18 |
Jun18 |
Sep18 |
Dec18 |
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
16.30 |
19.75 |
16.55 |
15.58 |
15.89 |
Competitive Comparison of China Biologic Products Holdings's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, China Biologic Products Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Biologic Products Holdings's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, China Biologic Products Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where China Biologic Products Holdings's Price-to-Operating-Cash-Flow falls into.
China Biologic Products Holdings Price-to-Operating-Cash-Flow Calculation
China Biologic Products Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 119.99 | / | 6.682 |
| = | 17.96 |
China Biologic Products Holdings's Share Price of today is $119.99.
China Biologic Products Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.68.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
China Biologic Products Holdings (China Biologic Products Holdings) Business Description
Traded in Other Exchanges
N/A
Address
19 Chaoyang Park Road, 18th Floor, Jialong International Building, Chaoyang District, Beijing, CHN, 100125
China Biologic Products Holdings Inc is a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based products in China. The company operates its business through two majority owned subsidiaries, Shandong Taibang and Guizhou Taibang. China Biologic's product pipeline includes a variety of dosages across multiple product categories. Its principal products are human albumin and immunoglobulin for intravenous injection. All of the company's products are prescription medicines administered in the form of injections. China Biologic's sales model focuses on direct sales to hospitals and inoculation centers and is complemented by distributor sales.
Executives
| Zhijing Cbpo Liu |
officer: Corporate Vice President |
19 CHAOYANG PARK ROAD 18/F, JIALONG INTERNATIONAL BUILDING BEIJING F4 100125 |
| Sean Shao |
director |
21ST FLOOR, EVERBRIGHT BANK BUILDING, ZHUZILIN, FUTIAN DISTRICT, SHENZHEN, GUANGDONG F4 518040 |
| David Gao |
director, officer: Chief Executive Officer |
C/ BEIJING MED-PHARM CORPORATION 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462 |
| Albert Yeung |
director |
C/O BEIJING MED-PHARM CORPORATION 600 WEST GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462 |
| David Hui Li |
director |
C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 |
| Min Fang |
director |
UNIT 2206, BUND CENTER OFFICE TOWER NO. 222 YANAN ROAD (EAST) SHANGHAI F4 200002 |
| Zhijun Tong |
director |
C/O BMP SUNSTONE CORPORATION 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462 |
| Joseph Chow |
director |
10110 SORRENTO VALLEY ROAD SUITE C SAN DIEGO CA 92121 |
| Yungang Lu |
director |
4TH FLOOR, ZHONGDIAN INFORMATION TOWER 6 ZHONGGUANCUN S. ST., HAIDIAN DIST. BEIJING F4 100086 |
| Warburg Pincus Llc |
10 percent owner |
450 LEXINGTON AVENUE, NEW YORK NY 10017 |
| Wp X Biologics Llc |
director, 10 percent owner |
C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK X1 10017 |
| Warburg Pincus X Partners, L.p. |
director, 10 percent owner |
C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
| Warburg Pincus Private Equity X, L.p. |
director, 10 percent owner |
C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
| Warburg Pincus X Gp L.p. |
director, 10 percent owner |
C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
| Warburg Pincus X, L.p. |
director, 10 percent owner |
C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
China Biologic Products Holdings (China Biologic Products Holdings) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CBPO has been successfully added to your